Safety of percutaneous aortic valve insertion. A systematic review.

Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol (2010) 1.23

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation (2006) 9.83

Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34

The logistic EuroSCORE. Eur Heart J (2003) 4.94

Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation (2006) 3.94

Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol (2007) 3.82

Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation (2007) 3.44

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J (2008) 2.96

Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88

Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation (2006) 2.88

Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83

Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg (2006) 2.61

Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58

Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg (2007) 2.24

Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J (2008) 2.23

Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol (2006) 2.16

Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg (2008) 1.84

Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol (2008) 1.71

United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg (2008) 1.47

Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv (2007) 1.45

Minimally invasive transapical beating heart aortic valve implantation--proof of concept. Eur J Cardiothorac Surg (2006) 1.45

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg (2007) 1.40

Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2008) 1.40

Early and late outcomes of 1000 minimally invasive aortic valve operations. Eur J Cardiothorac Surg (2008) 1.39

Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg (2006) 1.21

The transapical approach for aortic valve implantation. J Thorac Cardiovasc Surg (2008) 1.05

Valvular surgery in octogenarians: operative risks factors, evaluation of Euroscore and long term results. Eur J Cardiothorac Surg (2005) 1.04

Unoperated patients with severe aortic stenosis. J Am Coll Cardiol (2007) 0.99

Surgical "league tables": ischaemic heart disease. Heart (2008) 0.94

Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg (2008) 0.92

Management of the elderly patient with aortic stenosis. Heart (2008) 0.84

Letter by Grover et al regarding article, "Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg First-in-Man study". Circulation (2007) 0.78

Percutaneous aortic valve implantation. The demise of classical aortic valve replacement? Eur Heart J (2008) 0.78

Caution over use of catheter ablation for atrial fibrillation. BMJ (2013) 1.99

Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data. Europace (2013) 1.95

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions. Int J Technol Assess Health Care (2011) 1.71

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium. Europace (2009) 1.42

Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ (2012) 1.14

Questionable levels of evidence in new atrial fibrillation guidelines? Europace (2012) 1.05

Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis. BMC Pulm Med (2010) 0.95

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening. Int J Technol Assess Health Care (2009) 0.90

Pre-market clinical evaluations of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care (2012) 0.86

Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart (2012) 0.84

Market introduction of innovative high risk medical devices: towards a recast of the directive concerning medical devices. Eur J Health Law (2011) 0.78

Harmonizing HTA. Int J Technol Assess Health Care (2010) 0.75

Authors' reply to Ward. BMJ (2013) 0.75

The use of instrumental variables: an alternative to traditional modeling? Value Health (2011) 0.75

What is the evidence in favor of percutaneous aortic valve insertion? Am J Cardiol (2009) 0.75

Health technology assessment on catheter ablation of atrial fibrillation in Belgium. Europace (2013) 0.75

Introduction of emerging medical devices on the market: a new procedure in Belgium. Int J Technol Assess Health Care (2007) 0.75

Towards more consistent use of generic quality-of-life instruments. Pharmacoeconomics (2010) 0.75

TAVI: reveal the truth, the whole truth, and nothing but the truth. J Med Econ (2013) 0.75